#fundamental data

Stock fundamental data is basically the information that helps you understand a company's financial health and value. This data includes things like earnings, revenue, debt, and profit margins. Investors use this data in fundamental analysis to decide if a stock is a good investment.

Key Elements of Stock Fundamental Data:

Earnings per Share (EPS): How much profit a company makes per share of stock.

Price-to-Earnings (P/E) Ratio: A way to see if a stock is overvalued or undervalued.

Revenue: The total amount of money the company makes.

Dividend Yield: The return an investor gets from dividends.

Debt-to-Equity Ratio: How much debt a company has compared to its equity.

Return on Equity (ROE): Shows how well a company uses its resources to make money.

What Is Fundamental Analysis?

Fundamental analysis is when you look at a company’s financial health to decide if its stock is worth buying. You use data from things like the company's earnings, debt levels, and growth potential.

Why Is Stock Fundamental Data Important?

It helps you understand if a company is strong financially and if its stock is priced fairly. If a company is making consistent profits and has low debt, it might be a good investment.

Where Do You Get This Data?

Company Reports: Like income statements and balance sheets.

Stock Websites: Sites like Yahoo Finance or Google Finance.

APIs: You can use platforms like Alpha Vantage or Yahoo Finance API to get real-time stock data.

How to Use It:

Look at the key data points, compare them to other companies in the same industry, and check the trends over time. This will help you figure out whether a stock is worth buying or not.

The bubbles seem to have burst for National Beverage, maker of LaCroix soda water.

National Beverage, delightfully tickered as $FIZZ, took a 10 percent hit to its stock price on Tuesday. Why? Because a new lawsuit has emerged against the company, alleging that senior executives were preparing to declare that LaCroix soda cans are free of the toxic chemical Bisphenol A — which, the plaintiff in the lawsuit says, is misleading.

The plaintiff is a former National Beverage executive, Albert Dejewski, who also says that when he tried to raise his concerns to management, the company fired him.

Now, whistleblower complaints against large companies are not new, and for the record, National Beverage denies any wrongdoing. But the lawsuit did prompt a flurry of analyst notes about the company and its prospects, which don’t seem to rosy right now. (One analyst diplomatically called National Beverage “effectively in free fall.”)

So what do the numbers say? We pulled up the Company-in-Detail page for $FIZZ and looked.

Figure 1, below, compares National Beverage’s most recent quarterly filing to the year-ago period. Pretty much every number is moving in the wrong direction: revenue down, cost of sales up, gross profit down, SG&A expenses up, pretax income down. Heck, even the company’s provision for taxes is up. How often do you see that since Congress cut corporate taxes 18 months ago?

Then we jumped over to FIZZ’s footnote disclosures. Nothing to leave you feeling refreshed in those filings, either.

Sales by case volume were down 4.1 percent, “principally due to widespread media coverage of litigation regarding the marketing and labeling of LaCroix” — and those were prior lawsuits alleging contaminants in LaCroix, not to be confused with this whistleblower retaliation lawsuit filed this week. Costs were up due to higher fixed costs, including the price of aluminum and freight shipping.

The company’s cash position is still rising, but it rose only $19 million in the most recent quarter, compared to rising $26.2 million a year earlier. The company also reported a decrease in working capital because of a special cash dividend paid to shareholders last November that cost $135.2 million.

So perhaps surprising nobody, LaCroix’s share price has been tumbling for the better part of a year: from $124 per share last November, to $47.50 this week.